EGFR and non-small cell lung carcinoma: In conclusion, this study is the first time to describe that BDMC in combination with icotinib produced synergistic growth inhibitory effect on primary EGFR-TKI resistant NSCLC cells, through inductions of autophagic cell death, autophagy-dependent and -independent apoptosis.